Effect of mass drug administration on malaria incidence in southeast Senegal during 2020–22: a two-arm, open-label, cluster-randomised controlled trial
Authors
Abdoulaye Diallo
Tidiane Gadiaga
Tabitha Kibuka
Michelle E. Roh (ORCID: https://orcid.org/0000-0002-6268-0801)
Jean Louis Ndiaye (ORCID: https://orcid.org/0000-0003-0450-5551)
Effect of mass drug administration on malaria incidence in southeast Senegal during 2020–22: a two-arm, open-label, cluster-randomised controlled trial
Abdoulaye Diallo, Tidiane Gadiaga, Tabitha Kibuka, Michelle E. Roh et al.
Citations
9 citations
Journal
The Lancet Infectious Diseases
Topics
Malaria Research and Control
Field-Weighted Citation Impact (FWCI)
16.91
article
Effect of mass drug administration on malaria incidence in southeast Senegal during 2020–22: a two-arm, open-label, cluster-randomised controlled trial
Abdoulaye Diallo, Tidiane Gadiaga, Tabitha Kibuka, Michelle E. Roh, Jean Louis Ndiaye, Roly Gosling, Seynabou Gaye, Ibrahima Diallo, Doudou Sène, Paul J. Milligan, Julie Thwing, Adam Bennett, El Hadji Diouf, Fatou Ba, Alioune Badara Guèye, Erin Eckert, Xue Wu, El Hadj Bâ, Michelle S. Hsiang, Bayal Cissé, Jimee Hwang, Katharine Sturm‐Ramirez, Ari Fogelson, Aminata Collé Lô, Oumar Gallo Ba, Amadou Seck, Sylla Thiam, Moustapha Hama
article en
9 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet Infectious DiseasesVol. 25(6)
Institutions
Centers for Disease Control and Prevention (US), Program for Appropriate Technology in Health (US), University of California, San Francisco (US), United States Public Health Service (US), London School of Hygiene & Tropical Medicine (GB), U.S. President's Malaria Initiative (US), Global Brain Health Institute (US), Université de Thiès (SN)